Education
About Us
Working with TipRanks
Follow Us
PreveCeutical Medical (PRVCF)
:PRVCF
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -10.10K | C$ -9.86K | C$ -9.89K | C$ -5.09K | C$ -75.17K |
| Operating Income | C$ -812.47K | C$ -963.12K | C$ -1.10M | C$ -897.85K | C$ -2.14M |
| EBITDA | C$ -742.00 | C$ -955.09K | C$ -1.03M | C$ -1.28M | C$ -2.08M |
| Net Income | C$ -1.17K | C$ -1.27M | C$ -1.48M | C$ -1.73M | C$ -3.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 59.14K | C$ 1.43K | C$ 5.62K | C$ 16.06K | C$ 156.44K |
| Total Assets | C$ 225.66K | C$ 181.51K | C$ 189.14K | C$ 161.20K | C$ 302.45K |
| Total Debt | C$ 4.46M | C$ 3.83M | C$ 3.23M | C$ 2.93M | C$ 3.01M |
| Net Debt | C$ 4.40M | C$ 3.83M | C$ 3.23M | C$ 2.91M | C$ 2.86M |
| Total Liabilities | C$ 6.86M | C$ 5.96M | C$ 4.82M | C$ 4.27M | C$ 3.91M |
| Stockholders' Equity | C$ -6.64M | C$ -5.78M | C$ -4.64M | C$ -4.10M | C$ -3.60M |
| Cash Flow | |||||
| Free Cash Flow | C$ -428.49K | C$ -296.97K | C$ -222.64K | C$ -481.59K | C$ 61.94K |
| Operating Cash Flow | C$ -426.69K | C$ -296.97K | C$ -222.64K | C$ -426.39K | C$ 64.59K |
| Investing Cash Flow | C$ -1.80K | C$ 0.00 | C$ 850.00 | C$ -52.70K | C$ -2.65K |
| Financing Cash Flow | C$ 487.64K | C$ 293.62K | C$ 211.72K | C$ 136.75K | C$ 184.46K |
PreveCeutical Medical Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.